单胺氧化酶A介导的活性氧簇在心血管疾病中的作用

doi:10.19586/j.2095-2341.2023.0004

生物技术进展 ›› 2023, Vol. 13 ›› Issue (4): 542-546.DOI: 10.19586/j.2095-2341.2023.0004

• 进展评述 • 上一篇

单胺氧化酶A介导的活性氧簇在心血管疾病中的作用

代地林¹^,²^,³(), 吴园¹^,²^,³, 包明威¹^,²^,³()

^1.武汉大学人民医院心血管内科，武汉 430060
^2.武汉大学心血管病研究所，武汉 430060
^3.心血管病湖北省重点实验室，武汉 430060

收稿日期:2023-01-11 接受日期:2023-02-22 出版日期:2023-07-25 发布日期:2023-08-03
通讯作者: 包明威
作者简介:代地林 E-mail：2020203020006@whu.edu.cn；
基金资助:
国家自然科学基金项目(81770507)

The Effects of Reactive Oxygen Species Mediated by Monoamine Oxidase A in Cardiovascular Diseases

Dilin DAI¹^,²^,³(), Yuan WU¹^,²^,³, Mingwei BAO¹^,²^,³()

^1.Department of Cardiology，Renmin Hospital of Wuhan University，Wuhan 430060，China
^2.Cardiovascular Research Institute of Wuhan University，Wuhan 430060，China
^3.Hubei Key Laboratory of Cardiology，Wuhan 430060，China

Received:2023-01-11 Accepted:2023-02-22 Online:2023-07-25 Published:2023-08-03
Contact: Mingwei BAO

摘要/Abstract

摘要：

心血管疾病是人类最常见的死亡原因之一，其发病率逐年上升，因此，寻找有效的心血管疾病预防和诊治方法越来越迫切。单胺氧化酶A（monoamine oxidase A，MAO-A）是一种定位于线粒体外膜的黄素酶，负责5-羟色胺（5-hydroxytryptamine，5-HT）和去甲肾上腺素（norepinephrine，NE）的氧化脱氨，在这个过程中伴随过氧化氢（hydrogen peroxide，H₂O₂）、醛和氨等活性氧簇（reactive oxygen species，ROS）的堆积。过量产生的ROS通过靶向线粒体DNA，导致线粒体功能障碍，从而加速ROS的产生，这是引起心脏氧化应激和心脏损伤的主要原因。既往MAO-A抑制剂多用于精神及神经系统疾病的治疗，但MAO-A在心血管疾病中的作用直到最近才受到关注。基于以上研究发现，系统综述了MAO-A降解胺类物质生成的ROS在心血管疾病中的作用，以及作为治疗心血管疾病的潜力，以期为心血管疾病的治疗提供参考数据。

关键词: 单胺氧化酶A, 活性氧簇, 神经递质, 心血管疾病

Abstract:

Cardiovascular disease is one of the most common causes of death in the world， and its incidence rate is increasing annually. Therefore， it is becoming increasingly urgent to find effective methods for prevention， diagnosis and treatment of cardiovascular disease. Monoamine oxidase A （MAO-A）， a flavoenzyme located in the outer membrane of mitochondria， is responsible for the oxidative deamination of 5-hydroxytryptamine （5-HT） and norepinephrine （NE）， where accompanied by the accumulation of reactive oxygen species （ROS）， such as hydrogen peroxide （H₂O₂）， aldehyde and ammonia. Excessively produced ROS leads to mitochondrial dysfunction by targeting mitochondrial DNA， thereby accelerating ROS production， which is the main cause of cardiac oxidative stress and cardiac injury. Previously， MAO-A inhibitors were mostly used for the treatment of mental and nervous system diseases， but the roles of MAO-A in cardiovascular diseases have not been concerned until recently. Based on the above research findings， the role of ROS produced by MAO-A degradation of amines in cardiovascular diseases and its potential as a treatment for cardiovascular diseases were systematically reviewed， which was expected to provide reference for cardiovascular diseases treatment.

Key words: monoamine oxidase A, reactive oxygen species, neurotransmitter, cardiovascular disease

中图分类号:

R331.3+6

代地林, 吴园, 包明威. 单胺氧化酶A介导的活性氧簇在心血管疾病中的作用[J]. 生物技术进展, 2023, 13(4): 542-546.

Dilin DAI, Yuan WU, Mingwei BAO. The Effects of Reactive Oxygen Species Mediated by Monoamine Oxidase A in Cardiovascular Diseases[J]. Current Biotechnology, 2023, 13(4): 542-546.

参考文献 34

1	《中国心血管健康与疾病报告2021》编写组.《中国心血管健康与疾病报告2021》概述[J]. 中国心血管病研究, 2022,20(7):577-596.
2	WANG J, CHENG C, XIN C, et al.. The antidepressant-like effect of flavonoids from trigonella foenum-graecum seeds in chronic restraint stress mice via modulation of monoamine regulatory pathways[J/OL]. Molecules, 2019, 24(6): 1105[2022-11-24]. .
3	SAGLIK B N, OSMANIYE D, ACAR C U, et al.. Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective mao-b inhibitors[J]. J. Enzyme. Inhib. Med. Chem., 2020, 35(1): 1422-1432.
4	李鹏飞, 何荣华, 王琼涛, 等. 单胺氧化酶对老年心力衰竭患者临床应用价值[J]. 医学信息, 2018,31(17):78-80.
5	PODOBNIK J, NIKOLAC P M, NEDIC E G, et al.. Detention in juvenile correctional facilities is associated with higher platelet monoamine oxidase b activity in males[J/OL]. Biomolecules, 2020, 10(11): 1555[2022-11-24]. .
6	AMER A, HEGAZI A H, ALSHEKH M K, et al.. Design, synthesis, molecular modelling and in vitro screening of monoamine oxidase inhibitory activities of novel quinazolyl hydrazine derivatives[J/OL]. R. Soc. Open. Sci., 2020, 7(4): 200050[2022-11-12]. .
7	HUANG C, XIONG J, GUAN H D, et al.. Discovery, synthesis, biological evaluation and molecular docking study of (r)-5-methylmellein and its analogs as selective monoamine oxidase a inhibitors[J]. Bioorg. Med. Chem., 2019, 27(10): 2027-2040.
8	COSTINITI V, SPERA I, MENABO R, et al.. Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury[J]. Biochim. Biophys. Acta. Mol. Basis. Dis., 2018, 1864(9): 3050-3059.
9	WATSON A, GOULD E, PENFOLD S A, et al.. Diabetes and hypertension differentially affect renal catecholamines and renal reactive oxygen species[J/OL]. Front. Physiol., 2019, 10: 309[2022-10-18]. .
10	SANTIN Y, FAZAL L, SAINTE-MARIE Y, et al.. Mitochondrial 4-hne derived from mao-a promotes mitoca(2+) overload in chronic postischemic cardiac remodeling[J]. Cell Death. Differ., 2020, 27(6): 1907-1923.
11	PETRIE J R, GUZIK T J, TOUYZ R M. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms[J]. Can. J. Cardiol., 2018, 34(5): 575-584.
12	MIALET-PEREZ J, SANTIN Y, PARINI A. Monoamine oxidase-a, serotonin and norepinephrine: synergistic players in cardiac physiology and pathology[J]. J. Neural. Transm. (Vienna), 2018, 125(11): 1627-1634.
13	CHEN Q, WANG Q, ZHU J, et al.. Reactive oxygen species: key regulators in vascular health and diseases[J]. Br. J. Pharmacol., 2018, 175(8): 1279-1292.
14	LIU Y, WANG Z, LI J, et al.. Inhibition of 5-hydroxytryptamine receptor 2b reduced vascular restenosis and mitigated the beta-arrestin2-mammalian target of rapamycin/p 70s6k pathway[J/OL]. J. Am. Heart Assoc., 2018,7(3): e6810[2022-11-24]. .
15	KIM H, KIM Y G, CHOI W, et al.. Generation of a highly efficient and tissue-specific tryptophan hydroxylase 1 knockout mouse model[J/OL]. Sci. Rep., 2018, 8(1): 17642[2022-12-04]. .
16	LIU C, JIANG X, LIU G, et al.. An ancient mutation in the tph1 gene is consistent with the changes in mammalian reproductive rhythm[J/OL]. Int. J. Mol. Sci., 2019, 20(23): 6065[2022-11-24]. .
17	DU C K, ZHAN D Y, AKIYAMA T, et al.. Myocardial interstitial levels of serotonin and its major metabolite 5-hydroxyindole acetic acid during ischemia-reperfusion[J]. Am. J. Physiol. Heart Circ. Physiol., 2017, 312(1): 60-67.
18	ZHANG X, LI L, WANG Y, et al.. The inhibition effects of shenmai injection on acetylcholine-induced catecholamine synthesis and secretion by modulating nicotinic acetylcholine receptor ion channels in cultured bovine adrenal medullary cells[J/OL]. Evid. Based Compl. Alternat. Med., 2020, 2020: 8514926[2022-12-04]. .
19	刘磊, 张晓云. 电针刺激迷走神经调控去甲肾上腺素治疗卒中的研究进展[J]. 军事医学, 2020, 44(10): 790-795.
20	DESHWAL S, FORKINK M, HU C H, et al.. Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes[J]. Cell Death Differ., 2018, 25(9): 1671-1685.
21	KALUDERCIC N, TAKIMOTO E, NAGAYAMA T, et al.. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload[J]. Circ. Res., 2010, 106(1): 193-202.
22	李晓霞, 邢军, 王磊, 等. 有氧运动调控去甲肾上腺素转运蛋白抑制心力衰竭大鼠交感神经过度兴奋[J]. 天津体育学院学报, 2023, 1:105-111.
23	SENA C M, LEANDRO A, AZUL L, et al.. Vascular oxidative stress: impact and therapeutic approaches[J/OL]. Front. Physiol., 2018, 9: 1668[2022-11-27]. .
24	MURAYA N, KADOWAKI D, MIYAMURA S, et al.. Benzbromarone attenuates oxidative stress in angiotensin ii- and salt-induced hypertensive model rats[J/OL]. Oxid. Med. Cell. Longev., 2018, 2018: 7635274[2022-11-27]. .
25	MARTINEZ-REVELLES S, GARCIA-REDONDO A B, AVENDANO M S, et al.. Lysyl oxidase induces vascular oxidative stress and contributes to arterial stiffness and abnormal elastin structure in hypertension: role of p38 mapk[J]. Antioxid. Redox Signal., 2017, 27(7): 379-397.
26	NORLANDER A E, MADHUR M S, HARRISON D G. The immunology of hypertension[J]. J. Exp. Med., 2018, 215(1): 21-33.
27	MOHAMMED H S, KHADRAWY Y A. Antidepressant and antioxidant effects of transcranial irradiation with 830 nm low-power laser in an animal model of depression[J]. Lasers Med. Sci., 2022, 37(3): 1615-1623.
28	LANDA-GALVAN H V, RIOS-CASTRO E, ROMERO-GARCIA T, et al.. Metabolic syndrome diminishes insulin-induced akt activation and causes a redistribution of akt-interacting proteins in cardiomyocytes[J/OL]. PLoS ONE, 2020, 15(1): e228115[2022-11-27]. .
29	KANG P T, CHEN C L, LIN P, et al.. Mitochondrial complex Ⅰ in the post-ischemic heart: reperfusion-mediated oxidative injury and protein cysteine sulfonation[J]. J. Mol. Cell. Cardiol., 2018, 121: 190-204.
30	WANG Q, SU H, LIU J. Protective effect of natural medicinal plants on cardiomyocyte injury in heart failure: targeting the dysregulation of mitochondrial homeostasis and mitophagy[J/OL]. Oxid. Med. Cell. Longev., 2022, 2022: 3617086[2022-12-04]. .
31	SHAH A K, BHULLAR S K, ELIMBAN V, et al.. Oxidative stress as a mechanism for functional alterations in cardiac hypertrophy and heart failure[J/OL]. Antioxidants (Basel), 2021, 10(6):931[2022-11-24]. .
32	DESHWA S, DI S M, DI L F, et al.. Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease[J]. Curr. Opin. Pharmacol., 2017, 33: 64-69.
33	MONTALVO-CASIMIRO M, GONZALEZ-BARRIOS R, MERAZ-RODRIGUEZ M A, et al.. Epidrug repurposing: discovering new faces of old acquaintances in cancer therapy[J/OL]. Front. Oncol., 2020, 10: 605386[2022-12-01]. .
34	HUUSKONEN C, HAMALAINEN M, PAAVONEN T, et al.. Monoamine oxidase A inhibition protects the myocardium after experimental acute volume overload[J]. Anatol. J. Cardiol., 2019, 21(1): 39-45.

单胺氧化酶A介导的活性氧簇在心血管疾病中的作用

The Effects of Reactive Oxygen Species Mediated by Monoamine Oxidase A in Cardiovascular Diseases

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 34

相关文章 0

编辑推荐

Metrics

本文评价